Drugs / Imipenem and Cilastatin Sodium
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06144060 Comparator | Dec 2023 → Jun 2024 | acute pyelonephritis | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Imipenem and Cilastatin Sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06144060 ↗ |